Funded Startups in Winterthur
Across these 9 Winterthur-area rounds, the largest disclosed amount is Medyria’s $2M on 2025-07-16, which sits well above the rest of the disclosed figures…
Across these 9 Winterthur-area rounds, the largest disclosed amount is Medyria’s $2M on 2025-07-16, which sits well above the rest of the disclosed figures (the next-largest disclosed round is Scewo’s $11M on 2023-12-27, while several others are in the hundreds of thousands or below). The page also shows a time cluster: 3 rounds with disclosed amounts land within a ~3.5-month window from 2024-06-18 (Borobotics $170K) to 2024-11-15 (Bainox, amount undisclosed), and additional disclosed rounds appear closely spaced through late 2023 (Scewo $11M on 2023-12-27; Aseptuva $60K on 2023-02-01; Borobotics $170K on 2024-06-18).
Sector and stage mix skew toward health and adjacent domains: Biotechnology (Medyria), Health Care (CARE; Scewo; Aseptuva), and AI (Acodis) account for multiple entries, while “Series Unknown” and “undisclosed” amounts recur frequently (5 with “Series Unknown” and 3 with “undisclosed” amounts). The temporal range of shown rounds runs from 2022-10-06 (Vatorex) through the most recent 2025-07-16 (Medyria).
Most recent rounds
9 shownRelated listings
Frequently asked
What’s the largest disclosed round on this Winterthur list, and does it clearly stand out versus the rest?
Medyria’s $2M (2025-07-16) is the largest disclosed amount. It is substantially larger than the smallest disclosed rounds on the page, such as Borobotics’ $170K (2024-06-18) and Aseptuva’s $60K (2023-02-01), while several other disclosed amounts cluster in the low hundreds of thousands or low single-digit millions.
Do the most recent rounds cluster into a narrow window, or are they evenly spread across 2022–2025?
They’re concentrated near the top of the date range: Medyria (2025-07-16) is the most recent, and multiple entries appear between 2023-11-01 (CARE) and 2024-11-15 (Bainox). Earlier disclosed rounds like Vatorex (2022-10-06, $1M) and Aseptuva (2023-02-01, $60K) show the earlier portion is less dense than late 2023 through 2024.
Which stage labels dominate, and how does that compare with rounds where the amount or stage is unclear?
“Series Unknown” is the most common stage label, appearing for Medyria (Series Unknown), Borobotics (Series Unknown), contactify (Series Unknown), Acodis (Series Unknown), and Bainox (Series A is an exception). Separately, 3 entries show “undisclosed” amounts: Bainox (2024-11-15), CARE (2023-11-01), and contactify (2023-06-22), limiting comparisons of size across those rounds.
Are any sectors over-represented in this Winterthur set, and do they form a recognizable cluster?
Health-adjacent categories show up repeatedly: Health Care appears for CARE (2023-11-01, undisclosed), Scewo (2023-12-27, $11M), and Aseptuva (2023-02-01, $60K). Biotechnology (Medyria, 2025-07-16, $2M) and AI (Acodis, 2022-12-12, undisclosed) add nearby domain coverage rather than a single-company specialty.
Are there outliers in disclosed size or sector that are worth prioritizing for outreach or diligence?
The size outlier is the disclosed high end (Scewo’s $11M on 2023-12-27) compared with smaller disclosed rounds like Borobotics $170K (2024-06-18) and Aseptuva $60K (2023-02-01). On the sector side, the list mixes hardware (Scewo), blockchain/crypto (Bainox, 2024-11-15, undisclosed), and agriculture (Vatorex, 2022-10-06, $1M), which suggests non-uniform thematic coverage rather than a single vertical monopoly.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.